Elaine Siegfried, MD: There’s tremendous work going on, and a lot of it is driven by investment from pharmaceutical companies in creating better treatments. Prior to very recently we had a handful of ...

The 4-part lecture, “Practical Application of Novel Targeted Strategies in Moderate-to-Severe Atopic Dermatitis” covered the pathogenesis of atopic dermatitis (AD), new insights into the ...

Once limited to nonspecific anti-inflammatory therapies, expanding treatment options for atopic dermatitis are allowing therapy to be individualized.

Scientists have identified a gene variant on chromosome 11 that is associated with an increased risk of atopic dermatitis. In a large genome-wide study the researchers scanned the genomes of more than ...

Each month, The Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. Lauren Ax, MSPAS, PA-C ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...

Efficacy of the investigational drug lebrikizumab is maintained in patients with moderate to severe atopic dermatitis for at least 1 year, according to new results from the phase 3 ADvocate1 and ...

Lloyd S. Miller, M.D., Ph.D., is Vice President, Immunodermatology Disease Area Leader for the Immunology Therapeutic Area at Janssen Research & Development, LLC., one of the Janssen Pharmaceuticals ...

Libtayo's approval for high-risk cutaneous squamous cell carcinoma offers a new immunotherapy option, targeting PD-1 ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window NEW YORK CITY -- ...

September 14 was the eighth World Atopic Dermatitis Day. Atopic dermatitis (AD) is a common, chronic, and recurrent inflammatory skin disease characterized by severe pruritus and eczematous lesions.

Please provide your email address to receive an email when new articles are posted on . Atopic dermatitis may be more prevalent and more severe in patients with skin of color, according to findings ...